Exploring anxiety as an influencing factor of the impact of exercise and mind-body prehabilitation on cognitive functioning among women undergoing breast cancer surgery.

Autor: Knoerl R; Phyllis F. Cantor Center for Research in Nursing and Patient Care Services, Dana-Farber Cancer Institute, Boston, MA, USA., Sannes TS; Division of Psychosocial Oncology and Palliative Care, Dana-Farber Cancer Institute, Boston, MA, USA., Giobbie-Hurder A; Division of Biostatistics, Department of Data Science, Dana-Farber Cancer Institute, Boston, MA, USA., Frank ES; Division of Breast Oncology, Dana-Farber Cancer Institute, Boston, MA, USA., McTiernan A; Division of Public Health Sciences, Fred Hutchinson Cancer Research Center, Seattle, WA, USA.; School of Medicine, University of Washington, Seattle, WA, USA., Winer EP; Medical Oncology, Yale Cancer Center, New Haven, CT, USA., Irwin ML; Department of Chronic Disease Epidemiology, Yale School of Public Health, New Haven, CT, USA., Ligibel JA; Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.
Jazyk: angličtina
Zdroj: Journal of psychosocial oncology [J Psychosoc Oncol] 2024; Vol. 42 (3), pp. 448-456. Date of Electronic Publication: 2023 Dec 04.
DOI: 10.1080/07347332.2023.2282021
Abstrakt: Objective: The purpose of this secondary analysis was to describe the prevalence of anxiety, depression, and perceived stress among women newly diagnosed with breast cancer and the impact of baseline and changes in anxiety on cognitive functioning following exercise and mind-body prehabilitation interventions.
Methods: The sample consisted of 49 women with newly diagnosed breast cancer (stages I-III) who planned to undergo breast cancer surgery at two academic cancer centers. Participants were randomized to receive an exercise or mind-body prehabilitation intervention between the time of diagnosis and breast cancer surgery. Participants completed self-report measures of anxiety, depression (HADS), perceived stress, and cognitive functioning (EORTC-QLQ-C30) at study enrollment and prior to surgery (post-intervention). The relationships between change in cognitive functioning and change in anxiety among all participants were estimated using linear regression modeling.
Results: A significant proportion of women with newly diagnosed breast cancer had clinically significant anxiety (34.0%). Greater anxiety was moderately associated with worse cognitive functioning ( r = -0.33) at baseline. Linear modeling found that changes in cognitive functioning and anxiety were inversely related: Each one-unit decrease in anxiety was associated with a two-unit improvement in cognitive function ( p  = .06).
Conclusions: Anxiety was common in women with newly diagnosed breast cancer and was related to worse cognitive functioning. Assessment of anxiety at the time of diagnosis may allow for earlier anxiety management and subsequent improvement in cognitive functioning.
Databáze: MEDLINE